# US 2026/0060685 A1 · Devices, systems, and methods for managing blood flow

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0060685 A1
- Document ID: US20260060685A1
- Status: Published application
- Kind: A1
- Application number: 19/386,177
- Filed: 2025-11-11
- Published: 2026-03-05
- Earliest claimed: 2024-04-02
- Assignees: Revascardio Ltd.
- Applicants: Revascardio Ltd.
- Inventors: Shahaf MARMOR; Oded MEIRI; Assaf ALON; Chaim Zeev ABER; David Shlomo CHAYEN
- Web page: https://patentgrep.com/patent/US20260060685A1

## CPC

- A61B 17/12036: {partial occlusion}
- A61B 5/0215: by means inserted into the body
- A61B 17/00234: {for minimally invasive surgery (A61B17/0218, A61B17/0469, A61B17/12013, A61B17/1285, A61B17/29, A61B17/320016 take precedence)}
- A61B 17/11: for performing anastomosis; Buttons for anastomosis
- A61B 17/1204: {temporary occlusion}
- A61B 17/12109: {in a blood vessel}
- A61B 17/12122: {within the heart (for closing a cardiac septal defect A61B17/0057)}
- A61B 17/12136: {Balloons}
- A61B 17/12172: {having a pre-set deployed three-dimensional shape (methods of manufacturing A61B2017/00526)}
- A61B 17/12177: {comprising additional materials, e.g. thrombogenic, having filaments, having fibers or being coated}
- A61B 17/34: Trocars; Puncturing needles
- A61B 90/06: {Measuring instruments not otherwise provided for}
- A61M 27/002: {Implant devices for drainage of body fluids from one part of the body to another (intraocular A61F9/00781; middle ear A61F11/202)}
- A61B 2017/00004: {(bio)absorbable, (bio)resorbable or resorptive}
- A61B 2017/00022: {Sensing or detecting at the treatment site}
- A61B 2017/00252: {for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel}
- A61B 2017/00876: {magnetic}
- A61B 2017/1107: {for blood vessels}
- A61B 2017/1139: {Side-to-side connections, e.g. shunt or X-connections}
- A61B 2017/1205: {Introduction devices}
- A61B 2090/064: {for measuring force, pressure or mechanical tension}
- A61F 2/90: characterised by a net-like or mesh-like structure
- A61F 2002/068: {Modifying the blood flow model, e.g. by diffuser or deflector}
- A61M 2205/04: implanted
- A61M 2205/3331: Pressure; Flow
- A61M 2210/125: Heart
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

Devices, systems, and methods for causing retrograde oxygenated blood flow in at least a portion of the venous system of the myocardium are disclosed. Devices and methods include a method for causing retrograde oxygenated blood flow in at least a portion of the venous system of the myocardium, the method comprising: implanting a variable occluder in a coronary sinus region proximate a left atrium, wherein the variable occluder is configured to gradually increase a level of blood flow restriction over a period of days to enable a venous system of the myocardium to compensate for increased pressure caused by the gradual increase in the level of blood flow restriction; and following venous system compensation, shunting oxygenated blood flow into the coronary sinus to cause retrograde flow of oxygenated blood in at least a portion of the venous system of the myocardium to thereby enable revascularization of the myocardium.

## Claims

### Claim at position 1

1-20. (canceled)

### Claim 21

A device for promoting venous system compensation to enable retrograde blood flow in at least a portion of the venous system of the myocardium, the device comprising:
a support configured for implantation within a coronary sinus at a location proximate a left atrium, the support being adapted to transition between a compressed state for delivery within the coronary sinus and an expanded state for fixation within the coronary sinus, the support in the expanded state including a passageway therethrough; and
a variable occluder associated with the support, the variable occluder being configured to gradually increase a level of antegrade blood flow restriction through the passageway over a period of days to enable at least a portion of the venous system of the myocardium to compensate for increased pressure caused by the gradual increase in the level of antegrade blood flow restriction, wherein the variable occluder is further configured to substantially occlude antegrade blood flow through the passageway when a pressure on an upstream side of the variable occluder reaches a threshold, and to cause retrograde flow in the at least a portion of the venous system of the myocardium on an upstream side of the variable occluder.

### Claim 22 (depends on 21)

The device of claim 21, wherein the threshold is between 20 and 30 mmHg.

### Claim 23 (depends on 21)

The device of claim 21, wherein the threshold is between 30 and 40 mmHg.

### Claim 24 (depends on 21)

The device of claim 21, wherein the variable occluder includes at least one perforated sheet.

### Claim 25 (depends on 21)

The device of claim 21, wherein the variable occluder includes at least one flap.

### Claim 26 (depends on 25)

The device of claim 25, wherein the at least one flap is movable and configured to move in a manner limiting blood flow through the passageway in response to changes in the pressure on the upstream side of the variable occluder.

### Claim 27 (depends on 25)

The device of claim 25, wherein the at least one flap is configured to progressively restrict antegrade blood flow through the passageway as antegrade blood flow force on the flap decreases.

### Claim 28 (depends on 25)

The device of claim 25, wherein the at least one flap includes at least one sheet of flexible material.

### Claim 29 (depends on 28)

The device of claim 28, wherein the at least one sheet includes a plurality of flexible sheets.

### Claim 30 (depends on 24)

The device of claim 24, wherein the variable occluder further includes a flexible frame element.

### Claim 31 (depends on 30)

The device of claim 30, wherein the flexible frame element includes a discontinuous perimeter configured to allow a tool to cross through the variable occluder.

### Claim 32 (depends on 30)

The device of claim 30, wherein the flexible frame element is associated with a flat sheet.

### Claim 33 (depends on 30)

The device of claim 30, wherein the flexible frame is coil shaped.

### Claim 34 (depends on 21)

The device of claim 21, wherein the variable occluder includes material configured to promote tissue growth and thereby inhibit blood flow through the passageway.

### Claim 35 (depends on 21)

The device of claim 21, wherein the variable occluder includes a perforated sheet extending over an opening of the passageway, and a flap configured to adhere to the opening to thereby seal the opening when the pressure on the upstream side of the variable occluder reaches the threshold.

### Claim 36 (depends on 21)

The device of claim 21, wherein the variable occluder is further configured to be permanently disabled after the period of days to enable retrograde flow in the coronary sinus.

### Claim 37 (depends on 21)

The device of claim 21, wherein the variable occluder is configured to be permanently disabled by a tool configured to cross the variable occluder.

### Claim 38 (depends on 21)

The device of claim 21, wherein the variable occluder is further configured to at least partially allow blood flow passage through the passageway at a first flow volume when the pressure on the upstream side of the variable occluder is above 60 mmHg.

### Claim 39 (depends on 38)

The device of claim 38, wherein the variable occluder is further configured to restrict blood flow passage through the passageway to a second flow volume less than the first flow volume when the pressure on the upstream side of the variable occluder is below 30 mmHg.

### Claim 40 (depends on 21)

The device of claim 21, wherein the variable occluder is further configured to at least partially allow blood flow passage through the passageway at a first flow volume when the pressure on the upstream side of the variable occluder is above 50 mmHg.

### Claim 41 (depends on 21)

The device of claim 21, wherein the variable occluder is further configured to at least partially allow blood flow passage through the passageway at a first flow volume when the pressure on the upstream side of the variable occluder is above 40 mmHg.

### Claim 42 (depends on 21)

The device of claim 21, wherein the period of days spans weeks.

### Claim 43 (depends on 21)

The device of claim 21, wherein the period of days spans months.

### Claim 44 (depends on 21)

The device of claim 21, wherein the support includes a first section having a first diameter, and a second section having a second diameter greater than the first diameter.

### Claim 45 (depends on 44)

The device of claim 44, wherein the second diameter is sized to hinder migration of the support in the coronary sinus, and the first diameter is configured to support the variable occluder.

### Claim 46 (depends on 38)

The device of claim 38, wherein the variable occluder is further configured to restrict blood flow passage through the passageway to a second flow volume less than the first flow volume when the pressure on the upstream side of the variable occluder is below 20 mmHg.
